Skip to main content
Premium Trial:

Request an Annual Quote

Through the System

Science funding bills for fiscal year 2014 are wending their way through Congress, but the funding levels are typically lower in the House of Representative versions of the bills than in the Senate ones, the American Association for the Advancement of Science notes. For example, it says that there is a $400 million difference in funding for the National Science Foundation between the Senate and House versions of the Commerce, Justice, and Science bill. The Obama administration has threatened to veto sequester-level budgets, AAAS adds.

The American Association for Cancer Research argues that cuts to the US National Institutes of Health budget will exacerbate cancer health disparities. Margaret Foti, the CEO of AACR, says that to ensure health equity for cancer patients, "it is important that the administration and Congress provide sustained funding increases to the federal agencies, including the National Institutes of Health and the National Cancer Institute."

The Senate appropriations committee recently approved the bill that covers NIH funding at nearly what the Obama administration requested, according to AAAS. The House has yet to approve its version.

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.